Medherant: Chair for the clinic

University of Warwick spin-out Medherant Ltd has appointed Ken Cunningham as its chair right in time for the company’s move into the clinical development of its novel transdermal drug delivery patch technology. Cunningham is already Chairman of Abzena as well as Non-Executive Director of Verona Pharma plc. 

ADVERTISEMENT

Between 2006 and 2010, Cunningham was at SkyePharma plc, initially as Chief Operating Officer and subsequently as Chief Executive Officer. He holds a Medical Degree from St Mary’s, Imperial College London.

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!